QIU, YAO-LING,CAO, HUI,GAO, XURI,KASS, JORDAN,LI, WEI,PENG, XIAOWEN,SUH, BYUNG-CHUL,OR, YAT SUN
申请号：
CA3073986
公开号：
CA3073986A1
申请日:
2018.08.28
申请国别(地区):
CA
年份:
2019
代理人:
摘要：
The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof: which inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV life cycle of the hepatitis B virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HBV infection. The invention also relates to methods of treating an HBV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.
